Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels

Leukemia: Reduction Ratio and Halving Time of BCR: : ABL1 IS Transcript Levels

Objective: Achieving an early molecular response (EMR) is crucial for improving the prognosis of patients with chronic myeloid leukemia (CML). The halving time (HT) and reduction ratio (RR) of BCR: : ABL1 transcript levels have recently emerged as additional prognostic indexes besides the BCR: : ABL...

Full description

Bibliographic Details
Main Authors: Funda Ceran, Sema Akıncı, Mehmet Ali Uçar, Gülten Korkmaz, Mehmet Gündüz, Büşranur Çavdarlı, Şule Mine Bakanay, Mesude Falay, Simten Dağdaş, İmdat Dilek, Gülsüm Özet
Format: Article
Language:English
Published: Galenos Publishing House 2022-08-01
Series:Turkish Journal of Hematology
Subjects:
chronic myeloid leukemia
bcr: : abl1 is
halving time
reduction ratio
molecular response
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-93609

Internet

https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-93609

Similar Items